Abstract:Abstract Background Stress hyperglycemia ratio (SHR) is a new biomarker of true acute hyperglycemia, which is significantly related to emergency cardiovascular events. However, the relationship between SHR and long-term prognosis of patients with multi-vessel coronary artery disease has not been reported. The purpose of this study is to clarify the relationship between SHR and long-term clinical outcomes in patients with multi-vessel coronary artery disease (MVD). Methods A total of 1719 patients with multi-vessel coronary artery disease were included in the final analysis of this study. Patients were divided into three groups according to the SHR quartile: [SHR1 group (SHR ≤ 0.913), (n=573); SHR2 group (SHR 0.913-1.215), n=573; and SHR3 group (SHR ≥ 1.215), n=573]. All patients were followed up. The main end point was 5-year all-cause mortality. The secondary end point was the major cardiovascular and cerebrovascular adverse event (MACCE), defined as the combined result of 5-year all-cause death, myocardial infarction, stroke and subsequent coronary revascularization. Cox regression and Kaplan-Meier curve analysis were used to evaluate the relationship between SHR and all-cause mortality and MACCE. Logistic regression analysis and subject working curve (ROC) analysis were used to obtain the optimal critical value of SHR for predicting all-cause mortality and MACCE. Results During the average follow-up period of 4.5 years, 131 patients died of all causes, 121 patients suffered from myocardial infarction, 55 patients suffered from stroke and 247 patients underwent coronary artery revascularization. Compared with SHR1 and SHR2 groups, the all-cause mortality and MACCE in SHR3 group were significantly increased (4.36% and 8.03% and 10.47%; 20.94% and 31.06% and 44.68%, P<0.001, respectively). Kaplan-Meier curve showed that compared with SHR2 and SHR1 patients, SHR3 patients had the highest all-cause mortality and MACCE risk (Logarithmic ranking P<0.001). Multivariate Cox regression analysis showed that SHR was associated with a 1.462 and 1.205 fold increase in all-cause mortality and MACCE risk (HR 1.462; 95% CI 1.104-2.159; HR 1.205; 95% CI 1.073-1.932; P<0.001). ROC curve analysis showed that the best SHR threshold for predicting all-cause mortality and MACCE were 0.92 and 1.03, respectively. Conclusion Our data show for the first time that SHR is independently associated with poor long-term prognosis in patients with multi-vessel coronary artery disease. The best SHR thresholds for predicting all-cause mortality and MACCE in patients with MVD were 0.92 and 1.03, respectively. These findings suggest that SHR may play a potential role in the cardiovascular risk stratification of patients with MVD.

The relative and combined ability of triglyceride-glucose index and stress hyperglycemia ratio to predict major adverse cardio-cerebral events in patients with multivessel coronary artery disease

High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study

Triglyceride-glucose index and hsCRP-to-albumin ratio as predictors of major adverse cardiovascular events in STEMI patients with hypertension

The combined effect of triglyceride-glucose index and high-sensitivity C-reactive protein on cardiovascular outcomes in patients with chronic coronary syndrome: A multicenter cohort study

High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study

The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease

Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

Effects of the stress hyperglycemia ratio on long-term mortality in patients with triple-vessel disease and acute coronary syndrome

Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-IV database

Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome

Triglyceride-glucose index as a potential predictor of major adverse cardiovascular and cerebrovascular events in patients with coronary heart disease complicated with depression

Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension

Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes

Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease

Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention

Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome

Association of Triglyceride Glucose-Derived Indices with Recurrent Events Following Atherosclerotic Cardiovascular Disease

Relationship between stress hyperglycemia ratio and long-term poor prognosis in patients with multi-vessel coronary artery disease

Triglyceride-Glucose Index as a Predictor of Major Adverse Cardiovascular Events in Post-PCI Patients Diagnosed with In-Stent Restenosis

Association Between Triglyceride and Glycose (tyg) Index and Subclinical Myocardial Injury.

The association between triglyceride-glucose index and related parameters and risk of cardiovascular disease in American adults under different glucose metabolic states